|
| View All Articles About 'Drug' |
|
| 3. |
Ranbaxy settles patent dispute with Pfizer over Lipitor, other drugs
India's largest generics durgmaker Rnbaxy Laboratories, which has agreed to become a subsidiary of Japanese drugmaker Daiichi Sankyo for $4.6 billion, pulled off a coup of sorts, announcing it has settled certain patent disputes with Pfizer over its $13 billion blockbuster anti-cholesterol drug Lipitor (generic name Atorvastatin) and other drugs.
16 Jun 2008 |
| 4. |
Japanese drugmaker Daiichi Sankyo gobbles Ranbaxy Laboratories for $4.6 billion
In what is seen as India's biggest acquisition deal in the pharmaceutical sector, Japanese drugmaker Daiichi Sankyo Co. said it has reached an agreement with India's largest generics drugmaker Ranbaxy Laboratories Ltd. which will see the former acquire the latter's majority stake for around $4.6 billion (£2.3 billion).
14 Jun 2008 |
| 9. |
Glaxo and Synta drug gets orphan status from FDA
Pharmaceutical company GlaxoSmithKline PLC and the American based Synta Pharmaceuticals have said that the US Food and Drug Administration (FDA) has granted the drug Elesclomol, orphan drug status. Elesclomol is a medicine meant to treat metastatic melanoma.
30 Jan 2008 |
| 10. |
US May Peg Aid to Mexico Extraditions
The United States wants to tie a $1.5 billion anti-drug aid package in part to Mexico's performance in extraditing suspects, a top State Department official said Wednesday.
24 Jan 2008 |
|
|
|
|
|
|
